Difference between revisions of "Profiles"
Jump to navigation
Jump to search
Line 4: | Line 4: | ||
==Stage 3: Technically Confirmed== | ==Stage 3: Technically Confirmed== | ||
− | * | + | * [[Media:QIBA FDG-PET Profile v104 06Nov2013.doc|FDG-PET/CT for Response to Cancer Therapy 2013-11-06]] ? |
==Stage 2: Publicly Reviewed== | ==Stage 2: Publicly Reviewed== | ||
− | * | + | * |
==Stage 1: Public Comment== | ==Stage 1: Public Comment== | ||
* [[Media:QIBA FDG-PET Profile v103 rev 09Mar2013-PK wFDG-TC-Roster.pdf|FDG-PET/CT for Response to Cancer Therapy 2013-03-09]] (''Public Comment ended May 24, 2013'') | * [[Media:QIBA FDG-PET Profile v103 rev 09Mar2013-PK wFDG-TC-Roster.pdf|FDG-PET/CT for Response to Cancer Therapy 2013-03-09]] (''Public Comment ended May 24, 2013'') | ||
+ | * [[Media:DCEMRIProfile v1 6-20111213.pdf|DCE-MRI Quantification 2011-12-13]] (''Public Comment ended Feb 2012'') | ||
* [[Media:2011 07 28 Profile CT Advanced Disease V2 0f.pdf|CT Volumetry for Advanced Disease 2011-07-08]] (''Public Comment ended Sept 2011'') | * [[Media:2011 07 28 Profile CT Advanced Disease V2 0f.pdf|CT Volumetry for Advanced Disease 2011-07-08]] (''Public Comment ended Sept 2011'') | ||
+ | |||
==See Also== | ==See Also== | ||
*[[How to use QIBA Profiles]] | *[[How to use QIBA Profiles]] | ||
*[[Work Product for Review]] | *[[Work Product for Review]] |
Revision as of 01:26, 4 May 2016
Profiles published here have completed one of the QIBA Profile Stages of development.
Stage 3: Technically Confirmed
Stage 2: Publicly Reviewed
Stage 1: Public Comment
- FDG-PET/CT for Response to Cancer Therapy 2013-03-09 (Public Comment ended May 24, 2013)
- DCE-MRI Quantification 2011-12-13 (Public Comment ended Feb 2012)
- CT Volumetry for Advanced Disease 2011-07-08 (Public Comment ended Sept 2011)